search.noResults

search.searching

saml.title
dataCollection.invalidEmail
note.createNoteMessage

search.noResults

search.searching

orderForm.title

orderForm.productCode
orderForm.description
orderForm.quantity
orderForm.itemPrice
orderForm.price
orderForm.totalPrice
orderForm.deliveryDetails.billingAddress
orderForm.deliveryDetails.deliveryAddress
orderForm.noItems
Follow us on twitter: @csjmagazine


NEWS


Report highlights need to improve care for pregnant women with COVID-19


Findings from the MBRRACE-UK 2021 rapid report, Learning from SARS-CoV-2- related and associated maternal deaths in the UK June 2020-March 2021, suggest that there needs to be wider awareness of how best to treat pregnant and postnatal women with COVID-19. The report authors reviewed the care of all pregnant and postnatal women who died with SARS-CoV-2 infection, and women who died and whose care or engagement with care was influenced by changes as a consequence of the pandemic between 1 June 2020 and 1 March this year. Fourteen women died with SARS-CoV-2 infection, ten from COVID-19 and four from other causes, three further women’s deaths were influenced by changes as a consequence of the pandemic.


Only one out of ten women who died from COVID-19 was treated in accordance with the evidence-based guidance developed by the Royal College of Obstetricians and Gynaecologists and Royal College of Midwives (https://www. rcog.org.uk/en/guidelines-research-services/ guidelines/coronavirus-pregnancy/). This comprehensive national guidance should be followed wherever pregnant or postpartum women are cared for. The report also highlights a need to ensure early senior involvement of the maternal medical team, understand the needs of the woman herself and avoid withholding treatment due to misplaced concerns over her pregnancy. The report also noted ongoing indirect impacts such that women are fearful of seeking care and may delay presentation or not present at all. Other pregnancy complications remain many times more frequent than COVID-19 in pregnancy, and the need to ensure women are able to access the care they need is essential.


This includes making sure that women are confident about their safety in attending face-to-face visits, but also recognising situations in which remote consultations are inadequate. This may be for several reasons including language difficulties, lack of access to appropriate technology, repeated presentation, clinical complexity or potentially severe or high-risk conditions. Prof Marian Knight, lead author of


the report said: “It is unacceptable that women with COVID-19 do not receive the best quality of care simply because they are pregnant or recently pregnant. The RECOVERY trial ensured inclusion of pregnant and postpartum women to make


sure that we had the evidence about how best to treat their COVID-19...We must ensure that the cultural and structural biases around treatment in pregnancy and the postnatal period are tackled to ensure that women receive the care they need.” Prof Jenny Kurinczuk, lead for


MBRRACE-UK, said: “Maternal deaths from COVID-19 in the UK are uncommon, but this report highlights, once again, the importance of prevention of severe illness through vaccination. All pregnant and postpartum women are eligible to receive a COVID-19 vaccine as part of the UK programme.” The report is available at www.npeu. ox.ac.uk/mbrrace-uk/reports


The Haemostat Absorbing Your Cost Pressures Oxidised Cellulose Haemostat


• Faster Haemostasis • Faster Absorption • Easier to Position • Huge Savings to be made


info@uniplexuk.com www.uniplexuk.com 0114 241 3410


SEPTEMBER 2021 WWW.CLINICALSERVICESJOURNAL.COM l 9


©Photographee.eu - stock.adobe.com


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44  |  Page 45  |  Page 46  |  Page 47  |  Page 48  |  Page 49  |  Page 50  |  Page 51  |  Page 52  |  Page 53  |  Page 54  |  Page 55  |  Page 56  |  Page 57  |  Page 58  |  Page 59  |  Page 60  |  Page 61  |  Page 62  |  Page 63  |  Page 64  |  Page 65  |  Page 66  |  Page 67  |  Page 68  |  Page 69  |  Page 70  |  Page 71  |  Page 72  |  Page 73  |  Page 74  |  Page 75  |  Page 76  |  Page 77  |  Page 78  |  Page 79  |  Page 80  |  Page 81  |  Page 82  |  Page 83  |  Page 84  |  Page 85  |  Page 86  |  Page 87  |  Page 88